ESPNNebraska's latest recruit? An alien in HBO's 'Lanterns'CNN TürkŞanlıurfa’da ‘uçakta patlayıcı var’ notu ekipleri harekete geçirdiESPN DeportesFalcons toman vuelo en New OrleansPunchUS tracks suspected Russian plague scare, 200 under observationInquirerMan nabbed after allegedly yielding shabu, firearm in Ilocos SurThe Jerusalem PostFormer hostage Emily Damari calls out denial, distortion of October 7, thanks British supporters
KioskNews
The Daily Newsstand · Free, Always
Tuesday, October 6, 2026
Language
Seeking Alpha·United States·

Ginkgo Bioworks surges 21%; up 120% over last month

Translate

Jonathan Block

Business graph, chart green background.Copy space

design master

  • Gingko Bioworks (DNA) closed Monday up ~21% as options trading surged.
  • The stock has been on a tear of late. Over the last month, shares are up ~120%. The biggest news for Gingko over that time happened in mid-September when it signed an agreement with Lilly TuneLab, a collaborative drug discovery platform established by Eli Lilly (LLY).
  • Gingko Bioworks saw an unusually high amount of options trading on Monday. Investors purchased 10,531 call options, an 898% increase compared to the average daily volume of 1,055 call options.
View the original on Seeking Alpha →

KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.